| Line item | 2025-09-30 FY | 2024-09-30 FY | 2023-09-30 FY | 2022-09-30 FY | 2021-09-30 FY |
|---|---|---|---|---|---|
| Revenue | – | – | – | – | – |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $51.41M | $52.88M | $55.76M | -$50.99M | $42.00M |
| R&D | $37.59M | $41.84M | $43.72M | $37.92M | $32.98M |
| SG&A | $13.82M | $11.04M | $12.04M | $13.07M | $9.02M |
| Operating Income | -$51.41M | -$52.88M | -$55.76M | -$50.99M | -$42.00M |
| Interest Expense | – | – | – | – | – |
| Tax Expense | – | – | – | – | – |
| Net Income | -$46.38M | -$43.00M | -$47.51M | -$47.98M | -$37.91M |
| EPS (basic) | -0.5400 | -0.5200 | -0.6000 | -0.6200 | -0.5400 |
| EPS (diluted) | -0.5400 | -0.5200 | -0.6000 | -0.6200 | -0.5400 |
| Shares (diluted) | $85.29M | $83.47M | $79.79M | $76.91M | $69.80M |